Log in
Enquire now
‌

US Patent 8367663 Phosphoinositide 3-kinase inhibitors with a zinc binding moiety

Patent 8367663 was granted and assigned to Curis (company) on February, 2013 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors
Patent abstract

The instant application relates to deazapurines, thienopyrimidines and furopyrimidines with zinc-binding moiety based derivatives and their use in the treatment of phosphoinositide 3-kinase related diseases and disorders such as cancer. The instant application further relates to the the treatment of histone deacetylase related disorders and diseases related to both histone deacetylase and phosphoinositide 3-kinase.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 8367663 Phosphoinositide 3-kinase inhibitors with a zinc binding moiety

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo